Dr Erin Duffy
Chief of Research & Development
CARB-X
Dr Jon Iredell
Director Centre for Infectious Diseases & Microbiology
Westmead Institute for Medical Research
Dr Paul Turner
Rachel Carson Professor of Ecology & Evolutionary Biology
Yale University
Dr Danish Malik
Reader in Industrial Biotechnology
Loughborough University
Dr Carrie-Lynn Langlais Furr
CEO & Co-Founder
Bacteriophage & Drug Development Consultants LLC
Dr Gina Suh
Infectious Disease Specialist
Mayo Clinic
Frenk Smrekar
CEO & Co-Founder
JAFRAL Ltd
Dr Steven Theriault
CEO & CSO
Cytophage Technologies Inc.
Dr. Steven Theriault is a passionate scientist with 20 years of research and entrepreneurial experience in generating biological solutions for biological problems. He founded Cytophage Technologies Inc., a company that uses natural, modified and synthetic bacteriophages to create a diversity of products that combat bacterial infections affecting human health, animal health and food security. Dr. Theriault’s goal is to enable bacteriophages to become mainstream for treating human and animal bacterial infections, thereby averting the WHO’s predicted AMR crisis and avoiding needless suffering.
Dr Xavier Duportet
CEO & Co-Founder
Eligo Bioscience
Hien Zhao
Director of Neuroscience Research
Ionis Pharmaceuticals